Paraplatin "Authorized" Generic To Be Launched By Teva
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol's chemotherapeutic agent is expected to have pediatric exclusivity through mid-October, but Teva's version will come to market in June.